The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.90
Bid: 51.94
Ask: 51.96
Change: 0.02 (0.04%)
Spread: 0.02 (0.039%)
Open: 51.88
High: 52.34
Low: 51.88
Prev. Close: 51.88
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

8 Nov 2016 17:45

RNS Number : 6753O
Lloyds Banking Group PLC
08 November 2016
 

Publication of Final Terms

 

The following Final Terms are available for viewing:

Final Terms dated 8 November 2016, for Lloyds Banking Group plc €638,865,000 0.750 per cent. Notes due 2021 (the "2021 Notes") and Lloyds Banking Group plc €777,802,000 1.000 per cent. Notes due 2023 (the "2023 Notes", together with the 2021 Notes, the "Notes") issued pursuant to the base prospectus dated 17 May 2016 as supplemented by the supplemental prospectuses dated 28 July 2016 and 26 October 2016 (the "Prospectus") in connection with the £50,000,000,000 Euro Medium Term Note Programme established by Lloyds Bank plc and Lloyds Banking Group plc.

The Final Terms for the Notes contain the final terms of the Notes. The Final Terms of the Notes must be read in conjunction with the Prospectus, which constitutes a base prospectus for the purposes of the Prospectus Directive (Directive 2003/71/EC), as amended.

To view the full documents, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/6753O_-2016-11-8.pdfhttp://www.rns-pdf.londonstockexchange.com/rns/6753O_1-2016-11-8.pdfA copy of the Final Terms and the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.

For further information, please contact:

Shella Ali

Corporate Media Relations Manager

Tel: +44 (0) 20 7356 2017

Email: shella.ali@lloydsbanking.com

 

Investor Relations:

Douglas Radcliffe

Group Investor Relations Director

Tel: +44 (0) 20 7356 1571

Email: douglas.radcliffe@finance.lloydsbanking.com

 

Lloyds Banking Group plc

Registered Office

The Mound

Edinburgh

EH1 1YZ

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

In particular, the Prospectus does not constitute an offer of securities for sale in the United States. This announcement is not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the Notes in the United States.

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFTBRBDBIXGBGLI
Date   Source Headline
26th Oct 20231:02 pmRNSPublication of Suppl.Prospcts
26th Oct 202312:59 pmRNSPublication of Suppl.Prospcts - Correction
25th Oct 202312:09 pmRNSPublication of Suppl.Prospcts
25th Oct 202311:57 amRNS2023 Q3 Interim Management Statement
25th Oct 20237:00 amRNS2023 Q3 Interim Management Statement
11th Oct 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
21st Sep 20231:28 pmRNSPublication of Final Terms
20th Sep 20232:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:00 pmRNSDirector/PDMR Shareholding
13th Sep 20232:00 pmRNSBoard and Committee changes
13th Sep 20231:45 pmRNSDirector/PDMR Shareholding
13th Sep 20239:20 amRNS2023 Half-Year Results
31st Aug 202312:00 pmRNSTotal Voting Rights
29th Aug 20237:21 amRNSCompletion of £2 billion Share Buyback Programme
25th Aug 20235:51 pmRNSTransaction in Own Shares
24th Aug 20235:38 pmRNSTransaction in Own Shares
24th Aug 20235:30 pmRNSTotal Voting Rights
23rd Aug 20235:21 pmRNSTransaction in Own Shares
22nd Aug 20235:18 pmRNSTransaction in Own Shares
22nd Aug 202311:44 amRNSPublication of Pricing Supplement
22nd Aug 20239:39 amRNSStabilisation Notice
21st Aug 20235:14 pmRNSTransaction in Own Shares
18th Aug 20235:37 pmRNSTransaction in Own Shares
17th Aug 20235:39 pmRNSTransaction in Own Shares
16th Aug 20235:29 pmRNSTransaction in Own Shares
15th Aug 20235:28 pmRNSTransaction in Own Shares
14th Aug 20235:36 pmRNSTransaction in Own Shares
11th Aug 20235:49 pmRNSTransaction in Own Shares
10th Aug 20235:42 pmRNSTransaction in Own Shares
10th Aug 20232:00 pmRNSDirector/PDMR Shareholding
9th Aug 20235:41 pmRNSTransaction in Own Shares
8th Aug 20235:29 pmRNSTransaction in Own Shares
7th Aug 20236:04 pmRNSTransaction in Own Shares
4th Aug 20235:19 pmRNSTransaction in Own Shares
3rd Aug 20235:28 pmRNSTransaction in Own Shares
31st Jul 20235:36 pmRNSTransaction in Own Shares
31st Jul 20234:00 pmRNSDirector/PDMR Shareholding
31st Jul 202312:00 pmRNSTotal Voting Rights
27th Jul 202310:00 amRNSDirector Declaration
26th Jul 20235:33 pmRNSTransaction in Own Shares
26th Jul 202312:18 pmRNSPublication of Suppl.Prospcts
26th Jul 202311:57 amRNS2023 Half-Year Results
26th Jul 202311:56 amRNS2023 Half-Year Results
26th Jul 20237:00 amRNS2023 Half-Year Results - Part 2 of 2
26th Jul 20237:00 amRNS2023 Half-Year Results - Part 1 of 2
14th Jul 20235:23 pmRNSTransaction in Own Shares
13th Jul 20235:26 pmRNSTransaction in Own Shares
12th Jul 20235:38 pmRNSTransaction in Own Shares
12th Jul 20234:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.